Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would consider new talks with insurers about the record costs of Wegovy and copyright should they pledge to help keep the medicines on their formularies. Previously this summer, https://kethek.com/